Tassin, A. (2024). Un axe DUX4 HIF1 dans la FSHD ? [Paper presentation]. Amis FSH - conférence de vulgarisation (zoom meeting), Lyon, France. |
  | Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (June 2024). Selection of peptides for a muscle-targeted delivery of ASOs directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo [Poster presentation]. 31th Annual FSHD Society International Research Congress, Denver, United States - Colorado.  Editorial reviewed |
 | Delpierre, A., Akan, M., Ris, L., Legrand, A., Decleves, A.-E., Villers, A., & Tassin, A. (24 April 2024). Muscle-to-brain communication under voluntary and forced exercise training applied in the context of obesity in mice [Paper presentation]. MYOLOGY 2024, Paris, France. Editorial reviewed |
 | Szczepanski, S., Limpens, M., Blommaert, V., Jenart, V., Legrand, A., Decleves, A.-E., & Tassin, A. (22 April 2024). Adiponectin pathway in murine models of skeletal muscle deconditioning and reconditioning [Poster presentation]. 8th International congress Myology. |
Decarnoncle, M., Pierre, L., Francois, L., Marechal, L., Zwakhals, T., Juszczak, F., Tassin, A., & Decleves, A.-E. (05 April 2024). Impact of myokines on AMPK activity in chronic kidney disease induced by obesity [Paper presentation]. The meeting ERCSG 2024, Broxbourne, United Kingdom. |
 | Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (April 2024). Selection of peptides for a muscle-targeted delivery of ASOs directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo [Poster presentation]. 8th International congress Myology, Paris, France. Editorial reviewed |
 | Paprzycki, L., Gourari, Y., Legrand, A., Debacq-Chainiaux, F., & Tassin, A. (April 2024). Effect of Episodic Hypoxaemia on skeletal muscle: which association with ApN pathway modifications? [Poster presentation]. 8th International Congress Myology, Paris, France. Editorial reviewed |
 | Nguyen, T. H., Limpens, M., Bouhmidi, S., Paprzycki, L., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (15 March 2024). The DUX4-HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected. International Journal of Molecular Sciences, 25 (332). doi:10.20944/preprints202211.0532.v2 Peer Reviewed verified by ORBi |
 | Nguyen, T.-H., Paprzycki, L., Legrand, A., Decleves, A.-E., Heher, P., Limpens, M., Belayew, A., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (16 December 2023). Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene. Skeletal Muscle, 13 (1), 21. doi:10.1186/s13395-023-00330-2 Peer Reviewed verified by ORBi |
Tassin, A. (2023). Un axe DUX4 HIF1 dans la FSHD ? Newsletter Amis FSH. |
 | Decarnoncle, M., Marlier, H., Lhoir, F., Francois, L., Marechal, L., Zwakhals, T., Juszczak, F., Decroo, C., Coppée, F., Tassin, A., Wattiez, R., & Decleves, A.-E. (01 December 2023). Organokine impact in obesity induced chronic kidney disease [Poster presentation]. GENDER DIFFERENCES IN RENAL DISEASE FOCUS ON DIABETES AND OBESITY, Garachico, Spain. |
 | Paprzycki, L., Gourari, Y., Legrand, A., DEBACQ-CHAINIAUX, F., & Tassin, A. (24 November 2023). Effect of Episodic Hypoxaemia on skeletal muscle: which association with Ad pathway modifications? [Poster presentation]. PhyPhar Autumn Meeting. |
 | Paprzycki, L., Gourari, Y., Legrand, A., Debacq-Chainiaux, F., & Tassin, A. (28 April 2023). Sustained Intermittent hypoxaemia as a component of COPD pathophysiology: which effect on skeletal muscle? [Paper presentation]. BELGIAN SOCIETY OF PHYSIOLOGY AND PHARMACOLOGY Spring Meeting 2023, Bruxelles, Belgium. Editorial reviewed |
Tassin, A., Mbolo ebubu, E. R., Vanpee, D., & Legrand, A. (2023). Développement d’un nouveau critère de jugement clinique pour la FSHD [Paper presentation]. FSHD time : Conférence de vulgarisation dédiée aux patients atteints de FSHD, La Louvière, Belgium. |
Decarnoncle, M., Pierre, L., Francois, L., Marechal, L., Zwakhals, T., Juszczak, F., Tassin, A., & Decleves, A.-E. (29 March 2023). Impact of myokines on AMPK activity in obesity-induced chronic kidney disease [Paper presentation]. Diabète de type 1 & Exercice physique : de la gestion des risques aux bénéfices pour la santé, Loos, France. |
 | Claus, C., Slavin, M., Ansseau, E., Lancelot, C., Bah, K., Lassche, S., Fievet, M., Greco, A., Tomaiuolo, S., Tassin, A., Dudome, V., Kusters, B., Decleves, A.-E., Laoudj-Chenivesse, D., van Engelen, B. G. M., Nonclercq, D., Belayew, A., Kalisman, N., & Coppée, F. (07 March 2023). The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins. Skeletal Muscle, 13 (1), 5. doi:10.1186/s13395-022-00310-y Peer Reviewed verified by ORBi |
Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (2023). Selection of peptides for a muscle-targeted delivery of ASO directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo [Paper presentation]. Physphar Spring meeting (2023), Brussels, Belgium. Editorial reviewed |
 | Szczepanski, S., Limpens, M., Decleves, A.-E., Legrand, A., & Tassin, A. (12 September 2022). Adiponectin pathway in a murine model of disuse muscle atrophy: in in vivo study [Poster presentation]. 7th International Myology Congress, Nice, France. Editorial reviewed |
Nguyen, T. H., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (12 September 2022). Relationship between DUX4 and Hypoxia-Inducible Factor (HIF1α) in human and murine muscle cells vitro and in vivo [Poster presentation]. International Myology Congress. Editorial reviewed |
 | Delpierre, A., Deroux, C., Akan, M., Ris, L., Decleves, A.-E., Legrand, A., Villers, A., & Tassin, A. (12 September 2022). Focus on the endocrine function of skeletal muscle: study of muscle-to-brain communication under voluntary and forced exercise applied in the context of obesity in mice [Poster presentation]. 7th International scientific congress "Myology 2022", Nice, France. Editorial reviewed |
Tchéoubi, E. S. R., Akpovi, C. D., Coppée, F., Tassin, A., Decleves, A.-E., Fiogbé, S. E., Sègbo, G. J., Laurent, S., & Burtea, C. (11 September 2022). PCSK9 variants affect differently the risk of type 2 diabetes mellitus development. Potential impact on the therapy with PCSK9 inhibitors [Poster presentation]. 12th International Symposium on Drug Analysis & 32nd International Symposium on Pharmaceutical and Biomedical Analysis. Peer reviewed |
 | LIMPENS, M., Derenne, A., Burtea, C., Legrand, A., Decleves, A.-E., Coppée, F., & Tassin, A. (17 June 2022). Towards a muscle-targeted delivery of antisense agents against DUX4 [Poster presentation]. The 29th FSHD Society's annual International Research Congress 2022. Editorial reviewed |
 | Heher, P., Ganassi, M., Weidinger, A., Engquist, E., Pruller, J., Nguyen, T. H., Tassin, A., Decleves, A.-E., Mamchaoui, K., Banerji, C., Grillari, J., Kozlov, A., & Zammit, P. (16 June 2022). Interplay between mitochondrial reactive oxygen species, oxidative stress, and hypoxic adaptation in FSHD: metabolic stress as a potential therapeutic target [Paper presentation]. FSHD Society international research congress 2022. Editorial reviewed |
 | Nguyen, T. H., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, R. S. C., Zammit, P., & Tassin, A. (16 June 2022). Relationship between DUX4 and Hypoxia-Inducible Factor (HIF1α) in human and murine muscle cells vitro and in vivo [Poster presentation]. FSHD Society international research congress 2022. Editorial reviewed |
 | Szczepanski, S., LIMPENS, M., Decleves, A.-E., Legrand, A., & Tassin, A. (29 April 2022). Adiponectin pathway in a murine model of disuse muscle atrophy: an in vivo study ? [Poster presentation]. Spring Meeting of the Belgian Society of Physiology and Pharmacology. Editorial reviewed |
 | Heher, P., Ganassi, M., Weidinger, A., Engquist, E. N., Pruller, J., Nguyen, T. H., Tassin, A., Decleves, A.-E., Mamchaoui, K., Banerji, C. R. S., Grillari, J., Kozlov, A. V., & Zammit, P. S. (25 January 2022). Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic target. Redox Biology, 51, 102251. doi:10.1016/j.redox.2022.102251 Peer Reviewed verified by ORBi |
 | Decarnoncle, M., Decroo, C., Coppée, F., Tassin, A., Tagliatti, V., Villers, A., Colet, J.-M., Nonclercq, D., Legrand, A., Ris, L., Wattiez, R., & Decleves, A.-E. (25 November 2021). Développement d'une trousse de dosage d'organokines par spectrométrie de masse [Poster presentation]. Networking EpiCURA-UMONS, Baudour, Belgium. |
Juszczak, F., Pierre, L., Arnould, T., Tassin, A., & Decleves, A.-E. (2021). AMPK dysregulation in chronic kidney disease: new insights into therapeutic strategies [Paper presentation]. 11th international meeting on AMPK, Evian, France. |
 | Nguyen, T. H., Conotte, S., Belayew, A., Decleves, A.-E., Legrand, A., & Tassin, A. (05 July 2021). Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies: Cause and Consequences. International Journal of Molecular Sciences, 22 (13). Peer Reviewed verified by ORBi |
Nguyen, T. H., Legrand, A., Decleves, A.-E., Heher, P., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (24 June 2021). Exploring the Relationship Between DUX4 and Hypoxia-Inducible Factor (HIF1α) [Poster presentation]. The 28 th FSHD Society's annual International Research Congress 2021. Editorial reviewed |
 | Delpierre, A., Deroux, C., Ris, L., Decleves, A.-E., Legrand, A., Villers, A., & Tassin, A. (25 May 2021). Muscle-to-Brain communication in the context of obesity: impact of physical exercise? [Paper presentation]. PhysPhar Spring meeting, Belgium. Editorial reviewed |
Juszczak, F., Decarnoncle, M., Tassin, A., & Decleves, A.-E. (14 May 2021). New insights into therapeutic strategies for obesity-induced chronic kidney disease: is there a role for AMPK [Paper presentation]. International Webinar on Nephrology, Urology and Kidney Failure, Webinar (Online Meeting), Unknown/unspecified. |
| Tassin, A., Szczepanski, S., & Delpierre, A. (2021). Approches translationnelles en réadaptation respiratoire, Conférence FRMH. |
Delpierre, A., Akan, M., Deroux, C., Jenart, V., Ris, L., Decleves, A.-E., Legrand, A., Villers, A., & Tassin, A. (30 March 2021). Effect of voluntary and forced exercise on FNDC5-Irisin pathway and muscle-to-brain crosstalk in a model of obesity [Poster presentation]. Mardi des chercheurs, Valenciennes, France. |
 | Juszczak, F., Vlassembrouck, M., Botton, O., Zwakhals, T., Decarnoncle, M., Tassin, A., Caron, N., & Decleves, A.-E. (31 December 2020). Delayed Exercise Training Improves Obesity-Induced ChronicKidney Disease by Activating AMPK Pathway in High-FatDiet-Fed Mice. International Journal of Molecular Sciences, 22 (1). doi:10.3390/ijms22010350 Peer Reviewed verified by ORBi |
Tassin, A., & Decleves, A.-E. (2020). AMPK activation : a therapeutic strategy against muscle metabolic alteration in FSHD : Vidéo. |
 | Pierard, M., Tassin, A., Legrand, A., & Legrand, A. (01 October 2020). Chronic hypoxaemia and gender status modulate adiponectin plasmatic level and its multimer proportion in severe COPD patients: new endotypic presentation? BMC Pulmonary Medicine, 20 (255). doi:10.1186/s12890-020-01288-3 Peer reviewed |
 | Derenne, A., Tassin, A., Nguyen, T. H., DeRoeck, E., Jenart, V., Ansseau, E., Belayew, A., Coppée, F., Decleves, A.-E., & Legrand, A. (2020). Induction of a local muscular dystrophy using electroporation in vivo: an easy tool for screening therapeutics. Scientific Reports. Peer reviewed |
 | Thayse, K., Brogniet, S., Carlier, S., Kindt, N., & Tassin, A. (13 February 2020). Comparison of Vascular Cell Adhesion Molecule-1 (VCAM-1) expression following stimulation with TNF alpha on human umbilical vein endothelial cells and EA.hy926 cells for atherosclerosis research [Paper presentation]. 39th Annual Belgian Society of Cardiology Meeting, Bruxelles, Unknown/unspecified. |
Conotte, S., Tassin, A., Delpierre, A., Zouaoui Boudjeltia, K., & Legrand, A. (31 January 2020). Contribution of oxidative stress to muscle dysfunction associated to chronic intermittent hypoxia : an interventional study in a murine model [Poster presentation]. 14th meeting of the FRS-FNRS Contact group on Oxidative Processes and Antioxidants, Mons, Belgium. |
 | Delpierre, A., Villers, A., Deroux, C., Ris, L., Decleves, A.-E., Legrand, A., & Tassin, A. (22 November 2019). Muscle-to-brain communication in the context of obesity : impact of physical exercise [Poster presentation]. Physphar Autumn Meeting, Bruxelles, Unknown/unspecified. Editorial reviewed |
Tassin, A., & Legrand, A. (2019). L'atteinte respiratoire dans la FSHD : - Conférence de vulgarisation scientifique. |
Juszczak, F., Vlassembrouck, M., Zwakhals, T., Jenart, V., Botton, O., Gaussin, J.-F., Jadot, I., Tassin, A., Legrand, A., Caron, N., & Decleves, A.-E. (08 September 2019). Role of AMP-activated Protein Kinase in Renal Lipid Accumulation in Obesity-induced Chronic Kidney Disease. Benefits of an Endurance Exercise Training in Mice [Poster presentation]. 4th European Workshop on AMPK, Louvain-la-Neuve, Belgium. |
Nguyen, T. H., Tassin, A., Decleves, A.-E., Figeac, N., Heher, P., Banerji, C. R. S., & Zammit, P. S. (20 June 2019). Exploring the Relationship Between DUX4 and Hypoxia-Inducible Factor (HIF1α) [Poster presentation]. FSH Society international research congress, Marseille, France. Editorial reviewed |
Delcourt, M., Delpierre, A., Tassin, A., Colet, J.-M., Decleves, A.-E., & Villers, A. (2019). L'obésité a encore frappé - Le fumarate et son rôle au sein du tissu adipeux. |
Nguyen, T. H., Derenne, A., Ansseau, E., De Roeck, E., Coppée, F., Decleves, A.-E., Tassin, A., & Legrand, A. (27 March 2019). Development of easy outcome measures for the in vivo screening of therapeutical agents targeting DUX4 in FSHD [Poster presentation]. MYOLOGY, Bordeaux, France. Editorial reviewed |
 | Derenne, A., Kouakou, C., Belayew, A., Decleves, A.-E., Tassin, A., Burtea, C., & Coppée, F. (08 March 2019). Development of peptides for specific skeletal muscle targeted drug delivery [Poster presentation]. 2019 Advances in Skeletal Muscle Biology in Health and Disease, University of Florida, United States - Florida. Editorial reviewed |
 | Delpierre, A., Villers, A., Deroux, C., Ris, L., Decleves, A.-E., Legrand, A., & Tassin, A. (05 March 2019). Inter-communication muscle - cerveau dans un contexte d'obésité : Impact de l'exercice [Poster presentation]. Mardi des Chercheurs 2019 (MdC2019), Mons, Belgium. |
 | Pierard, M., Tassin, A., Conotte, S., Zouaoui, K., & Legrand, A. (2019). Sustained Intermittent Hypoxemia Induces Adiponectin Oligomers Redistribution and a Tissue-Specific Modulation of Adiponectin Receptor in Mice. Frontiers in Physiology. Peer reviewed |
 | Pierard, M., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (11 December 2018). Effect of hypoxia on adiponectin pathway in murine and cellular models: which involvement in COPD-associated cardiovascular risk ? [Poster presentation]. Europhysiology, London, United Kingdom. Editorial reviewed |
Nguyen, T. H., & Tassin, A. (2018). Etude du crosstalk entre DUX4 et HIF1α dans le cadre de la dystrophie Facio-Scapulo-Humérale (FSHD). |
Panamarova, M., Tassin, A., Belayew, A., & Zammit, P. (25 June 2018). Mapping D4Z4 - driven expression profile and dynamics in FSHD [Paper presentation]. New Directions in Biology and Disease of Skeletal Muscle Conference, New Orleans, United States - Louisiana. Editorial reviewed |
Tassin, A., & Legrand, A. (2018). L'importance du muscle au quotidien (A l'occasion de l'événement Carrefour des Générations, en collaboration avec l'ABMM). |
Juszczak, F., Vlassembrouck, M., Zwakhals, T., Jenart, V., Botton, O., Gaussin, J.-F., Jadot, I., Tassin, A., Legrand, A., Caron, N., & Decleves, A.-E. (12 April 2018). Role of AMP-Activated Protein Kinase in Renal Lipid Accumulation in Obesity-Induced Chronic Kidney Disease. Benefits of an Endurance Exercise Training in Mice [Paper presentation]. 30th Meeting of the European Renal Cell Study Group, Florence, Italy. |
Juszczak, F., Vlassembrouck, M., Tassin, A., Legrand, A., Caron, N., & Decleves, A.-E. (27 March 2018). Study of Renal Lipid Accumulation in Obesity-induced Chronic Kidney Disease in Mice. Benefits of an Endurance Exercise Training [Poster presentation]. Mardi des Chercheurs (MdC2018), Valenciennes, France. |
 | Conotte, S., Tassin, A., Conotte, R., Colet, J.-M., Zouaoui, K., & Legrand, A. (27 February 2018). Metabonomic profiling of chronic intermittent hypoxia in a mouse model. Respiratory Physiology and Neurobiology, 256, 157_173. doi:10.1016/j.resp.2018.02.015 Peer Reviewed verified by ORBi |
 | Vanderplanck, C., Tassin, A., Ansseau, E., Charron, S., Wauters, A., Lancelot, C., Vancutsem, K., Laoudj Chevinesse, D., Belayew, A., & Coppée, F. (12 January 2018). 'Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei'. Skeletal Muscle, 8 (2). doi:10.1186/s13395-017-0148-4 Peer reviewed |
Pierard, M., Conotte, S., Tassin, A., Zouaouia-Boudjeltia, K., & Legrand, A. (2017). Effect of hypoxia on adiponectin pathway in murine and cellular models: which involvement in COPD-associated cardiovascular risk? [Paper presentation]. Federation of European Physiological Societies (FEPS), Viennes, Austria. |
Derenne, A., Tassin, A., Burtea, C., Decleves, A.-E., & Coppée, F. (13 September 2017). Development of specific molecules using the phage display technology allowing a targeted drug delivery to skeletal muscles in the aim to treat muscular disorders.» [Paper presentation]. Journée PhD day EDT en Sciences Pharmaceutiques, Liège, Belgium. Editorial reviewed |
 | Derenne, A., De Roeck, E., Tassin, A., Coppée, F., Decleves, A.-E., & Legrand, A. (11 May 2017). DUX4 surexpression and silencing in a murine model [Poster presentation]. Interuniversity PhD student, Liège, Belgium. |
 | Panamarova, M., Tassin, A., Moyle, L., Belayew, A., & Zammit, P. (2017). Generation of a mouse model of FSHD to reveal the DUX4 expression profile and dynamics [Paper presentation]. 10th Neuromuscular Translational Research Conference, London, United Kingdom. |
Derenne, A., De Roeck, E., Tassin, A., Coppée, F., Belayew, A., Decleves, A.-E., & Legrand, A. (07 March 2017). DUX4 surexpression and silencing in a murine model [Poster presentation]. Mardi des Chercheurs (MdC2017), Mons, Belgium. |
 | Pierard, M., Tassin, A., Legrand, A., & Legrand, A. (07 March 2017). Adiponectin modulation in different COPD endotypes: a preliminary clinical study [Poster presentation]. Huitième édition montoise du MdC : le Mardi des Chercheurs 2017, UMons, Belgium. |
 | Pierard, M., Conotte, S., Tassin, A., Boutry, S., Uzureau, P., Zouaoui Boudjeltia, K., & Legrand, A. (2016). Interactions of exercise training and high-fat diet on adiponectin forms and muscle receptors in mice. Nutrition and Metabolism. doi:10.1186/s12986-016-0138-2 Peer Reviewed verified by ORBi |
Pierard, M., Delpierre, A., Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (30 June 2016). Modulations of adiponectin pathway inuced by hypoxia in murine and cellular models [Poster presentation]. Federation of European Physiological Societies, Paris, France. Editorial reviewed |
Conotte, S., Tassin, A., Nuyens, V., Zouaoui Boudjeltia, K., & Legrand, A. (2016). effect of chronic intermittent hypoxia on muscle function in a mouse model of obstructive sleep apnea [Paper presentation]. Federation of European Physiological Societies, Paris, France. |
Pierard, M., Delpierre, A., Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (2016). Modulations of adiponectin pathway induced by hypoxia in murin and cellular models [Paper presentation]. Federation of European Physiological Societies, Paris, France. |
  | Conotte, S., Tassin, A., Nuyens, V., Zouaoui Boudjeltia, K., & Legrand, A. (28 June 2016). effect of chronic intermittent hypoxia on muscle function in a mouse model of obstructive sleep apnea [Poster presentation]. Federation of European Physiological Societies, Paris, France. |
Pierard, M., Delpierre, A., Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (18 May 2016). Composante hypoxémique de la BPCO : quel impact sur les ADIPO-récepteurs ? [Poster presentation]. MDC 2016 Valenciennes, Valenciennes, France. |
 | Conotte, S., Tassin, A., Nuyens, V., Zouaoui Boudjeltia, K., & Legrand, A. (22 April 2016). effect of chronic intermittent hypoxia on muscle function in a mouse model of obstructive sleep apnea [Poster presentation]. 12th meeting of the FRS-FNRS Contact Group on oxidative stress and antioxydants : New Frontiers in Oxidative Stress and Redox Regulation, Louvain-la-Neuve, Belgium. |
 | Ansseau, E., O, J., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj Chevinesse, D., Wattiez, R., Harper, S., Belayew, A., & Coppée, F. (14 March 2016). The translocation of DUX4 and DUX4c during myoblast differentiation allows their association with nucleo-cytoplasmic proteins associated with mRNP granules [Poster presentation]. International Congress Of Myology, Lyon, France. |
 | Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (14 March 2016). 'Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy.' [Poster presentation]. 5th International Congress of Myology, Lyon, France. |
Ansseau, E., Eidal, J., Lancelot, C., Tassin, A., Matteotti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (2016). Homologous transcription factors DUX4 and DUX4c associate with cytoplasmic proteins during muscle differentiation. PLoS ONE. Peer reviewed |
Panamarova, M., Tassin, A., Moyle, L., Belayew, A., & Zammit, P. (05 January 2016). Generation of a mouse model of FSHD to reveal the DUX4 expression profile and dynamics [Paper presentation]. UK Neuromuscular Translational Research Conference, Oxford, United Kingdom. Editorial reviewed |
Pierard, M., Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (06 November 2015). Effect of continuous and intermittent hypoxia on adiponectin multimeric forms and muscle receptors in mice [Poster presentation]. autumn meeting Belgian Society of Physiology and Pharmacology, Bruxelles, Belgium. |
Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (06 November 2015). Cardiovascular alterations associated to intermittent hypoxia in a mouse model of obstructive sleep apnea (OSA) [Poster presentation]. autumn meeting Belgian Society of Physiology and Pharmacology, Bruxelles, Belgium. |
Ansseau, E., Eidahl, J. O., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (06 October 2015). The translocation of DUX4 and DUX4c during myoblast differentiation allows their association with nucleo-cytoplasmic proteins associated with mRNP granules [Paper presentation]. FSH society, Boston, United States - Massachusetts. |
Ansseau, E., Eidahl, J. O., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (04 October 2015). Unexpected location of DUX4/4c transcription factors in the cytoplasm suggests a role in mRNP granules and translation regulation [Poster presentation]. International World Muscle Society Congress, Brighton, United Kingdom. |
Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy [Paper presentation]. International World Muscle Society congress, Brighton, United Kingdom. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., & Belayew, A. (21 September 2015). Caveolar proteins : putative FSHD biomarkers [Poster presentation]. EMBO workshop : Molecular Mechanisms of muscle growth and wasting in health and disease, Ascona , Unknown/unspecified. |
Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (22 May 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy [Poster presentation]. Journée UMHAP from lab to bedside, Mons, Belgium. |
Pierard, M., Conotte, S., Boutry, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (12 May 2015). Effet de l'exercice physique sur l'adiponectine dans un modèle murin de syndrome métabolique [Poster presentation]. Journée scientifique du Pôle hainuyer (JSPH1), Mons, Belgium. |
Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (17 April 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of facioscapulohumeral muscular dystrophy (FSHD [Poster presentation]. Novel Therapies for monogennic diseases, Paris, France. |
Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (15 April 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy [Poster presentation]. symposium de thérapie génique du Collège de France, Paris, France. |
Conotte, S., Tassin, A., & Legrand, A. (2015). Des traces dans nos artères. |
Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (10 March 2015). Pathophysiological effects of a well-controlled exposure to intermittent hypoxia in mice : validation of a sleep apnea model [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (10 March 2015). Membrane proteins : putative FSHD biomarkers [Poster presentation]. 8ème édition de la Matinée de Chercheurs, Mons, Belgium. |
Pahulycz, L., Tassin, A., Conotte, S., Zouaoui Boudjeltia, K., Piagnerelli, M., & Legrand, A. (10 March 2015). Impact of hyperoxia in a murine model of intensive care unit myopathy [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Pahulycz, L., Piagnerelli, M., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (23 January 2015). Impact de l'hyperoxie sur la myopathie dans un modèle murin de sepsis [Poster presentation]. 43e Congrès International de la SRLF (Société de Réanimation de Langue Française), Paris, France. |
 | Robbe, A., Tassin, A., Carpentier, J., Decleves, A.-E., Mekinda Ngono, Z. L., Nonclercq, D., & Legrand, A. (09 January 2015). Intratracheal bleomycin aerosolization: the best route of administration for a scalable and homogeneous pulmonary fibrosis rat model? BioMed Research International, 2015 (198418), 1-9. doi:10.1155/2015/198418 Peer Reviewed verified by ORBi |
Lancelot, C., Tassin, A., Legrand, A., & Belayew, A. (2014). Interview radio et article internet - Le téléthon soutient aussi les chercheurs belges -. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (19 October 2014). Membrane proteins: putative FSHD biomarkers? [Poster presentation]. FSH Society international research consortium and research planning meeting, San Diego, United States - California. |
 | Ansseau, E., Matteoti, C., Tassin, A., Lancelot, C., Leroy, B., Hubeau, C., Nachtegael, C., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Meyer, P., Carnac, G., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (17 October 2014). Unexpected role for DUX transcription factors into the cytoplasm [Paper presentation]. International Research Consortium & Research Planning Meetings, San Diego, United States - California. |
Derenne, A., Tassin, A., Conotte, S., Coppée, F., Belayew, A., & Legrand, A. (17 October 2014). Comparison of two methods of naked DNA delivery in mice: which one is the most appropriate in the FSHD context? [Poster presentation]. FSH Society international research consortium and research planning meeting, San Diego, United States - California. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Coppée, F., Wattiez, R., & Belayew, A. (08 July 2014). Membrane proteins : putative FSHD biomarkers? [Poster presentation]. ICNMD 13th International Congress in NeuroMuscular Diseases, Nice, France. |
Lancelot, C., Ansseau, E., Tassin, A., Matteoti, C., Leroy, B., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (06 July 2014). Study of the double homeodomain DUX protein partners: focus on the interaction with desmin [Paper presentation]. IF-NMD Workshop Nice 2014 - Satellite Workshop to ICNMD, Nice, France. |
Tassin, A., Ansseau, E., Matteotti, C., Lancelot, C., Leroy, B., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (14 May 2014). Study of the double homeodomain DUX protein partners highlights DUX4c involvement in human muscle regeneration [Paper presentation]. EMBO Conference : Molecular Biology of Muscle Development and Regeneration, Acaya-Lecce, Italy. Editorial reviewed |
Pierard, M., Conotte, S., Boutry, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (05 April 2014). Effect of exercise training on adiponectin multimeric forms in a mouse model of metabolic syndrome [Paper presentation]. PhysPhar Meeting, Maastricht, Netherlands. Editorial reviewed |
Conotte, S., Tassin, A., & Legrand, A. (04 April 2014). Metabonomic profiling of intermittent hypoxia in a mouse model [Poster presentation]. PhysPhar Meeting, Maastricht, Netherlands. |
Pierard, M., Conotte, S., Boutry, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (04 April 2014). Effect of exercise training on adiponectin multimeric forms in a mouse model of metabolic syndrome [Poster presentation]. PhysPhar Meeting, Maastricht, Netherlands. |
| Vanderplanck, C., Tassin, A., Lancelot, C., Ansseau, E., Nonclercq, D., Delrée, P., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (27 November 2013). DUX4c, a DUX4-homologue, causes the FSHD disorganized myotube phenotype: an additional target for therapeutic strategies [Paper presentation]. Colloque Myogenèse XVI, Montpellier, France. |
| Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (24 May 2013). Evaluation of new antisense oligomers targeting the DUX4 mRNA [Poster presentation]. Journée de l'Institut de recherche en sciences et technologies de la santé, Mons, Belgium. |
 | Tassin, A., Vanderplanck, C., Ansseau, E., Derenne, A., Coppée, F., & Belayew, A. (24 May 2013). Different approaches to evaluate antisense strategies against the causal gene of the FSHD myopathy [Poster presentation]. Journée de l'Institut de recherche en sciences et technologies de la santé, Mons, Belgium. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (24 May 2013). Caveolar proteins: putative FSHD biomarkers? [Poster presentation]. 1st Health Institute Day, Mons, Belgium. |
Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (22 April 2013). Evaluation of new antisense oligomers targeting the DUX4 mRNA as a therapeutic strategy for FSHD [Paper presentation]. MDA Scientific Conference, Washington DC, United States - District of Columbia. |
 | Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (29 January 2013). Caveolar proteins: putative FSHD biomarkers? [Poster presentation]. ', Journée de l'école doctorale en sciences biomédicales et pharmaceutiques, UMONS, Mons, Belgium. |
 | Tassin, A., Laoudj-Chenivesse, D., Vanderplanck, C., Barro, M., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppée, F., & Belayew, A. (01 January 2013). DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? Journal of Cellular Molecular Medecine, 17 (1), 1-15. doi:10.1111/j.1582-4934.2012.01647.x Peer reviewed |
 | Tassin, A., Leroy, B., Laoudj-Chenivesse, D., Wauters, A., Vanderplanck, C., Le Bihan, M.-C., Coppée, F., Wattiez, R., & Belayew, A. (18 December 2012). FSHD Myotubes with Different Phenotypes Exhibit Distinct Proteomes. PLoS ONE, 7 (12), 51865. doi:10.1371/journal.pone.0051865 Peer reviewed |
 | Tassin, A., Vanderplanck, C., Leroy, B., Charron, S., Ansseau, E., Wauters, A., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (07 November 2012). Investigations on the FSHD disorganized myotube phenotype [Poster presentation]. FSH Society International Reasearch Consortium Meeting, San Francisco, United States. |
Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (06 November 2012). Evaluation of new antisense oligomers targeting the DUX4 mRNA as a therapeutic strategy for FSHD [Paper presentation]. FSH Society International Reasearch Consortium Meeting, San Francisco, United States. |
| Tassin, A., Laoudj-Chenivesse, D., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppée, F., & Belayew, A. (07 November 2011). Detection of endogenous DUX4 protein in FSHD muscles: could the spreading of a rare protein cause FSHD? [Poster presentation]. FSH Society International Research Consortium & Reasearch Planning Meeting, Boston, United States - Massachusetts. |
 | Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (01 November 2011). The FSHD atrophic myotube phenotype is caused by DUX4 expression and corrected by its suppression. PLoS ONE, 6 (10), 26820. doi:10.1371/journal.pone.0026820 Peer reviewed |
Tassin, A. (29 June 2011). Study of a deregulation cascade in FSHD primary myotubes by differential mass spectrometry [Paper presentation]. 7th Meeting of the London Myology Forum, Londres, United Kingdom. Editorial reviewed |
Tassin, A. (2011). Oral presentation for the MDC (Muscular Dystrophy Campaign). |
| Tassin, A., Leroy, B., Ansseau, E., Pire, E., Faille, J., Leclercq, T., Charron, S., Vanderplanck, C., Wauters, A., Turky, D., Laoudj-Chenivesse, D., Coppée, F., Wattiez, R., & Belayew, A. (12 May 2011). The galectin-1 gene is activated in FSHD Myotubes as a result of the DUX4 transcriptional deregulation cascade [Poster presentation]. 4th international congress of myology 2011, Lille , France. |
Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Charron, S., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (12 May 2011). Interfering with the transcription deregulation cascades in fshd [Paper presentation]. 4th international congress of myology 2011, Lille , France. |
Vanderplanck, C., Ansseau, E., Charron, S., Tassin, A., Turki, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (06 May 2011). SUPPRESSION OF DUX4 OR DUX4C EXPRESSION BY ANTISENSE STRATEGIES IN A THERAPEUTIC APPROACH FOR FSHD [Paper presentation]. 7th AGTS Meeting, Melbourne, Australia. |
Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Charron, S., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (14 March 2011). Suppression of DUX4 or DUX4c protein expression by antisense strategies in a therapeutic approach for FSHD [Paper presentation]. MDA national scientific conference Neuromuscular Therapeutic Strategies: Overcoming the Barriers from Microscope to Marketplace, Las Vegas, United States - Nevada. |
Tassin, A., Leroy, B., Ansseau, E., Pire, E., Faille, J., Leclercq, T., Charron, S., Laoudj-Chenivesse, D., Coppée, F., Wattiez, R., & Belayew, A. (25 November 2010). Focus on nuclear proteins of FSHD primary myotubes by differential mass spectrometry [Poster presentation]. VIIIè journées annuelles Société Française de Myologie, Nice, France. |
Tassin, A., Leroy, B., Ansseau, E., Pire, E., Charron, S., Coppée, F., Wattiez, R., & Belayew, A. (25 October 2010). Focus on nuclear proteins of FSHD primary myotubes by differential mass spectrometry [Poster presentation]. FSHD International Research Consortium Meeting, Boston, United States - Massachusetts. |
Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (21 October 2010). Suppression of DUX4 or DUX4c protein expression by antisense strategies as a therapeutic approach for FSHD [Paper presentation]. FSH Society International Research Consortium & Research Planning Meeting, Boston, United States - Massachusetts. |
Charron, S., & Tassin, A. (27 February 2010). Contribution à l'étude de la FSHD [Paper presentation]. Troisième journée sur les Maladies Rares, Radiorg, Bruxelles, Belgium. |
Tassin, A., Coppée, F., Leroy, B., Sauvage, S., Preillon, J., Erculisse, V., Charron, S., Vanderplanck, C., Barro, M., Vander Elst, L., Muller, R., Laoudj-Chenivesse, D., Colet, J.-M., Wattiez, R., & Belayew, A. (09 November 2009). Investigations on the molecular mechanism of a muscular dystrophy (FSHD) by proteomic and metabonomic analyses of primary myoblast cultures [Paper presentation]. FSH Society International Research Consortium and Research Planning Meetings, Boston, United States - Massachusetts. Editorial reviewed |
 | Tassin, A., Charron, S., Vanderplanck, C., Coppée, F., & Belayew, A. (2009). Des techniques en 'omique' pour comprendre une maladie héréditaire des muscles. |
Tassin, A., & Belayew, A. (31 October 2009). Etude des protéines DUX4, DUX4c, PITX1 et de leur rôle dans le mécanisme moléculaire de la FSHD [Paper presentation]. Assemblée Générale des Amis FSH Europe, Agde, France. |
 | Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Tassin, A., Vanderplanck, C., Sauvage, S., Barro, M., Mahieu, I., Leroy, A., Leclercq, I., Mainfroid, V., Figlewicz, D., Mouly, V., Butler-Browne, G., Belayew, A., & Coppée, F. (01 October 2009). DUX4c Is Up-Regulated in FSHD. It Induces the MYF5 Protein and Human Myoblast Proliferation. PLoS ONE, 4 (10), 7482. doi:10.1371/journal.pone.0007482 Peer reviewed |
Tassin, A., Coppée, F., Leroy, B., Erculisse, V., Sauvage, S., Charron, S., Vanderplanck, C., Barro, M., Vander Elst, L., Muller, R., Laoudj-Chenivesse, D., Colet, J.-M., Wattiez, R., & Belayew, A. (27 July 2009). Investigations on the molecular mechanism of a muscular dystrophy (FSHD) by proteomic and metabonomic analyses of primary myoblast cultures [Paper presentation]. International Symposium Signal transduction and disease, Aachen, Germany. Editorial reviewed |
Tassin, A. (12 June 2009). Etude de la surexpression de DUX4, DUX4c et PITX1 et du protéome nucléaire des myotubes FSHD [Paper presentation]. Colloque 'jeunes chercheurs' de l'AFM (Association Française contre les Myopathies). Editorial reviewed |
 | Bosnakovski, D., Xu, Z., Gang, E. J., Galindo, C. L., Liu, M., Simsek, T., Garner, H. R., Agha-Mohammadi, S., Tassin, A., Coppée, F., Belayew, A., Perlingeiro, R., & Kyba, M. (01 October 2008). An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO Journal, 27 (20), 2766-79. Peer Reviewed verified by ORBi |
Tassin, A., Vanderplanck, C., Ansseau, E., Marcowyzc, A., Barro, M., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (26 May 2008). Studies on the expression and function of DUX4c, a gene located close to the FSHD locus [Poster presentation]. 3ème Congrès International de Myologie, Marseille, France. |
Tassin, A., Ansseau, E., Vanderplanck, C., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Chen, Y.-W., Belayew, A., & Coppée, F. (21 January 2008). DUX4 and DUX4c activate different pathways in Facioscapulohumeral dystrophy [Paper presentation]. Colloque « Myogenese IX », Institut de Myologie, Paris, France. Editorial reviewed |
 | Tassin, A., Vanderplanck, C., Ansseau, E., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Dabauvalle, M. C., Wehnert, M., Chen, Y.-W., Belayew, A., & Coppée, F. (2008). Study of DUX4 and DUX4c in facioscapulohumeral muscular dystrophy [Paper presentation]. 13th International WMS Congress, Newcastle upon Tyne, United Kingdom. |
Ansseau, E., Tassin, A., Vanderplanck, C., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Chen, Y.-W., Belayew, A., & Coppée, F. (04 November 2007). Further studies on the DUX4, DUX4c and PITX1 genes in FSHD [Paper presentation]. FSHD international Workshop meeting, San Diego, United States - California. |
 | Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H., Sauvage, S., Mattéotti, C., van Acker, A., Leo, O., Figlewicz, D., Barro, M., Laoudj-Chenivesse, D., Belayew, A., Coppée, F., & Chen, Y.-W. (01 November 2007). DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proceedings of the National Academy of Sciences of the United States of America, 104 (46), 18157-18162. doi:10.1073/pnas.0708659104 Peer Reviewed verified by ORBi |
Tassin, A., Ansseau, E., Sauvage, S., Mattéotti, C., Van Acker, A.-M., Figlewicz, D., Laoudj-Chenivesse, D., Oberdan, L., Coppée, F., & Belayew, A. (18 December 2006). Evidence for the expression of the DUX4 gene in primary myoblasts of patients affected with Facioscapulohumeral muscular dystrophy [Poster presentation]. 194th Congrès de la Société Belge de Biochimie et de Biologie Moléculaire / 'Young Scientists Day, Gembloux, Belgium. |
 | Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Sauvage, S., Barro, M., Tassin, A., Mattéotti, C., van Acker, A., Leroy, A., Leclercq, I., Leo, O., Figlewicz, D., Belayew, A., & Coppée, F. (2006). Characterization of the DUX4c gene located within a repeated element close to the FSHD locus [Paper presentation]. 11th International Congress of the World Muscle Society, Bruges, Belgium. |
Ansseau, E., Tassin, A., Sauvage, S., Laoudj-Chenivesse, D., Barro, M., Figlewicz, D., Coppée, F., & Belayew, A. (09 October 2006). DUX4 gene expression in FSHD primary myoblasts [Paper presentation]. FSHD International Consortium Research Meeting, New Orleans, United States - Louisiana. |
Marcowycz, A., Mahieu, I., Tassin, A., Coppée, F., & Belayew, A. (17 May 2006). The DUX4 and DUX4c proteins, encoded by candidate genes for a muscular dystrophy (FSHD), have opposite functions in vivo [Poster presentation]. Bioforum, Liège, Belgium. |
 | Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Barro, M., Sauvage, S., Mattéotti, C., Mahieu, I., Tassin, A., Van Acker, A.-M., Leo, O., Fliglewicz, D., Coppée, F., & Belayew, A. (13 January 2006). Etude de DUX4 et DUX4c, gènes candidats pour la FSHD [Paper presentation]. Club muscle 'V', Paris, France. |
Tassin, A., Sauvage, S., Mattéotti, C., Van Acker, A.-M., Figlewicz, D., Padberg, G. W., Oberdan, L., Coppée, F., & Belayew, A. (25 October 2005). Studies on the expression of the DUX4 and DUX4c proteins [Poster presentation]. FSHD International Consortium Research Meeting, Salt Lake City, United States - Utah. |
Laoudj-Chenivesse, D., Barro, M., Sauvage, S., Tassin, A., Ansseau, E., Marcowycz, A., Figlewicz, D., Van Acker, A.-M., Leo, O., Belayew, A., & Coppée, F. (25 October 2005). Overexpression of the double homeodomain protein DUX4c in FSHD muscle [Paper presentation]. FSHD International Consortium Research Meeting, Salt Lake City, United States - Utah. |
Belayew, A., Ansseau, E., Sauvage, S., Marcowycz, A., Laoudj-Chenivesse, D., Carnac, G., Mattéotti, C., Gerbaux, C., Mahieu, I., Zorbo, S., Leclercq, I., Tassin, A., Figlewicz, D., & Coppée, F. (09 June 2005). Etude fonctionnelle de DUX4 et DUX4c, et de leur rôle dans la dystrophie de Landouzy-Dejerine [Paper presentation]. Meeting « Club Muscle IV », Marseille, France. |
Caron, N., Tassin, A., Devuyst, O., & Legrand, A. (29 November 2004). Effects of sodium nitroprusside and L-arginine on renal vascular resistance in rats with chronic renal failure [Paper presentation]. 37th Annual Meeting of the American Society of Nephrology, St Louis, United States. |
